Mitsushige Nishikawa

4.0k total citations · 1 hit paper
158 papers, 3.1k citations indexed

About

Mitsushige Nishikawa is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Mitsushige Nishikawa has authored 158 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Endocrinology, Diabetes and Metabolism, 35 papers in Molecular Biology and 27 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Mitsushige Nishikawa's work include Thyroid Disorders and Treatments (64 papers), Thyroid Cancer Diagnosis and Treatment (31 papers) and Growth Hormone and Insulin-like Growth Factors (13 papers). Mitsushige Nishikawa is often cited by papers focused on Thyroid Disorders and Treatments (64 papers), Thyroid Cancer Diagnosis and Treatment (31 papers) and Growth Hormone and Insulin-like Growth Factors (13 papers). Mitsushige Nishikawa collaborates with scholars based in Japan, United States and Canada. Mitsushige Nishikawa's co-authors include Toshiji Iwasaka, Mitsuo Inada, Akira Shouzu, Shosaku� Nomura, Seitaro Omoto, Nagaoki Toyoda, Hiroaki Matsubara, Hiroya Masaki, Hiroo Imura and S Fukuhara and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Biochemical and Biophysical Research Communications and Endocrinology.

In The Last Decade

Mitsushige Nishikawa

155 papers receiving 2.9k citations

Hit Papers

Long-Term Outcomes of Active Surveillance and Immediate S... 2023 2026 2024 2025 2023 20 40 60
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Long-Term Outcomes of Active Surveillance and Immediate Surgery for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma: 30-Year Experience
    2023 61 citations Akira Miyauchi, Yasuhiro Ito et al. Thyroid profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitsushige Nishikawa Japan 31 1.3k 876 703 385 301 158 3.1k
Markus Nauck Germany 29 933 0.7× 932 1.1× 415 0.6× 747 1.9× 262 0.9× 56 3.1k
Hideki Tahara Japan 28 1.0k 0.8× 466 0.5× 767 1.1× 530 1.4× 579 1.9× 75 3.3k
Hideyasu Kiyomoto Japan 32 1.3k 1.0× 1.0k 1.2× 1.3k 1.8× 730 1.9× 606 2.0× 106 3.9k
Andrew Advani Canada 35 960 0.7× 1.6k 1.9× 781 1.1× 677 1.8× 341 1.1× 104 3.9k
Thomas C. Wascher Austria 32 627 0.5× 972 1.1× 643 0.9× 383 1.0× 731 2.4× 112 3.0k
Mónica Rupérez Spain 27 821 0.6× 1.4k 1.6× 1.7k 2.4× 408 1.1× 321 1.1× 29 4.0k
J. Egido Spain 25 487 0.4× 983 1.1× 1.0k 1.4× 458 1.2× 238 0.8× 42 3.2k
Tomohito Gohda Japan 32 799 0.6× 651 0.7× 389 0.6× 361 0.9× 388 1.3× 127 3.1k
Michio Otsuki Japan 29 1.1k 0.8× 521 0.6× 278 0.4× 575 1.5× 383 1.3× 129 2.5k
Shinae Kang South Korea 25 708 0.5× 512 0.6× 695 1.0× 417 1.1× 342 1.1× 74 2.4k

Countries citing papers authored by Mitsushige Nishikawa

Since Specialization
Citations

This map shows the geographic impact of Mitsushige Nishikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsushige Nishikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsushige Nishikawa more than expected).

Fields of papers citing papers by Mitsushige Nishikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsushige Nishikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsushige Nishikawa. The network helps show where Mitsushige Nishikawa may publish in the future.

Co-authorship network of co-authors of Mitsushige Nishikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsushige Nishikawa. A scholar is included among the top collaborators of Mitsushige Nishikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsushige Nishikawa. Mitsushige Nishikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
M, Ito, Hiroyuki Yamaoka, Eijun Nishihara, et al.. (2025). Impact of Minimal Dose Strategy Before Antithyroid Drug Discontinuation on Relapse Risk in Graves’ Disease. The Journal of Clinical Endocrinology & Metabolism. 111(2). e368–e374.
2.
Nishihara, Eijun, Shuji Fukata, Mitsuyoshi Hirokawa, et al.. (2024). Nodule-Specific NRF2-Targeted Upregulation in Patients With KEAP1 Mutations and Familial Nontoxic Multinodular Goiter. The Journal of Clinical Endocrinology & Metabolism. 110(4). 973–982. 1 indexed citations
3.
M, Ito, Shuji Fukata, Takumi Kudo, et al.. (2024). Comparison of pathophysiology in subclinical hyperthyroidism with different etiologies. Endocrine Journal. 71(4). 373–381.
4.
Miyauchi, Akira, Yasuhiro Ito, Makoto Fujishima, et al.. (2023). Long-Term Outcomes of Active Surveillance and Immediate Surgery for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma: 30-Year Experience. Thyroid. 33(7). 817–825. 61 indexed citations breakdown →
5.
M, Ito, Tomohiko Nakamura, Toshihiko Kasahara, et al.. (2022). Proportion of serum thyroid hormone concentrations within the reference ranges in athyreotic patients on levothyroxine monotherapy: a retrospective study. Thyroid Research. 15(1). 9–9. 7 indexed citations
6.
Nishihara, Eijun, Yasuhiro Ito, Takumi Kudo, et al.. (2021). Favorable outcomes of papillary thyroid microcarcinoma concurrent with Graves’ disease after radioactive iodine therapy. Endocrine Journal. 68(6). 649–654. 1 indexed citations
7.
Toyoda, Nagaoki, et al.. (2011). Type 2 Iodothyronine Deiodinase Is Expressed in Human Preadipocytes. Thyroid. 21(3). 305–310. 20 indexed citations
8.
Nishikawa, Mitsushige. (2010). 1. Drug-induced Thyroid Dysfunction.. Nihon Naika Gakkai Zasshi. 99(4). 776–785. 1 indexed citations
9.
Nishioka, Hiroaki, et al.. (2010). Successful Permanent Catheter Implantation After Percutaneous Transluminal Angioplasty to the Right Subclavian and Inominate Vein Stenosis in a Hemodialysis Patient. Therapeutic Apheresis and Dialysis. 14(1). 108–111. 2 indexed citations
10.
Mori, Yasukiyo, Satoshi Tsujimoto, Kazuya Takehana, et al.. (2006). ‘Takotsubo’ Cardiomyopathy in a Maintenance Hemodialysis Patient. Therapeutic Apheresis and Dialysis. 10(1). 94–100. 14 indexed citations
11.
Mori, Yasukiyo, Kazuya Takehana, Hiroya Masaki, et al.. (2005). Assessment of Coronary Artery Disease in Hemodialysis Patients with Delayed Systolic Blood Pressure Response after Exercise Testing. Blood Purification. 23(6). 466–472. 2 indexed citations
12.
Yasuzawa-Amano, Saori, et al.. (2004). Expression and Regulation of Type 2 Iodothyronine Deiodinase in Rat Aorta Media. Endocrinology. 145(12). 5638–5645. 12 indexed citations
13.
Omoto, Seitaro, Shosaku� Nomura, Akira Shouzu, et al.. (1999). Significance of Platelet-Derived Microparticles and Activated Platelets in Diabetic Nephropathy. ˜The œNephron journals/Nephron journals. 81(3). 271–277. 84 indexed citations
14.
Tanaka, Kozo & Mitsushige Nishikawa. (1999). Glycosylated hemoglobin in chronic renal failure. 51(2-4). 125–131. 1 indexed citations
15.
Nishikawa, Mitsushige, Nagaoki Toyoda, Toshinaga Yonemoto, et al.. (1998). Quantitative Measurements for Type 1 Deiodinase Messenger Ribonucleic Acid in Human Peripheral Blood Mononuclear Cells: Mechanism of the Preferential Increase of T3 in Hyperthyroid Graves' Disease. Biochemical and Biophysical Research Communications. 250(3). 642–646. 15 indexed citations
16.
Mukuta, Toshio, Guillermo Arreaza, Mitsushige Nishikawa, et al.. (1997). Thyroid xenografts from patients with Graves' disease in severe combined immunodeficient mice and NIH-beige-nude-xid mice.. PubMed. 20(1). 5–15. 4 indexed citations
17.
YOSHIKAWA, NORIO, Toshiko Tokoro, Susumu Ikehara, et al.. (1996). IFN-γ Has a Protective Role against Thyroid-Specific Autoantibody Production in Severe Combined Immunodeficient (SCID) Mice Xenografted with Graves' Thyroid Tissue. Thyroid. 6(5). 437–443. 3 indexed citations
18.
Mori, Yasukiyo, Mitsushige Nishikawa, Hiroaki Matsubara, et al.. (1991). Regulation of atrial natriuretic hormone production by triiodothyronine in cultured rat atrial myocytes. European Journal of Endocrinology. 125(6). 694–699. 5 indexed citations
19.
Fukata, Junichi, Takeshi Usui, Yoshikatsu Nakai, et al.. (1990). Effects of Repetitive Administration of Corticotropin-Releasing Hormone Combined with Lysine Vasopressin on Plasma Adrenocorticotropin and Cortisol Levels in Secondary Adrenocortical Insufficiency*. The Journal of Clinical Endocrinology & Metabolism. 71(6). 1624–1631. 8 indexed citations
20.
Mashio, Yasuo, Mitsuo Inada, Kiyoshi Tanaka, et al.. (1983). Synaptosomal T3 binding sites in rat brain: their localization on synaptic membrane and regional distribution. European Journal of Endocrinology. 104(2). 134–138. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Markus Nauck Breakdown of academic impact, for papers by Hideki Tahara Breakdown of academic impact, for papers by Hideyasu Kiyomoto Breakdown of academic impact, for papers by Andrew Advani Breakdown of academic impact, for papers by Thomas C. Wascher Breakdown of academic impact, for papers by Mónica Rupérez Breakdown of academic impact, for papers by J. Egido Breakdown of academic impact, for papers by Tomohito Gohda Breakdown of academic impact, for papers by Michio Otsuki Breakdown of academic impact, for papers by Shinae Kang
Rankless by CCL
2026